KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Current Deferred Revenue: 2010-2022

Historic Current Deferred Revenue for Exelixis (EXEL) over the last 11 years, with Dec 2022 value amounting to $14.1 million.

  • Exelixis' Current Deferred Revenue fell 8.13% to $13.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $13.5 million, marking a year-over-year decrease of 8.13%. This contributed to the annual value of $14.1 million for FY2022, which is 15.00% down from last year.
  • Per Exelixis' latest filing, its Current Deferred Revenue stood at $14.1 million for FY2022, which was down 15.00% from $16.6 million recorded in FY2021.
  • Exelixis' Current Deferred Revenue's 5-year high stood at $182.9 million during FY2018, with a 5-year trough of $5.5 million in FY2021.
  • Its 3-year average for Current Deferred Revenue is $10.7 million, with a median of $10.3 million in 2020.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first slumped by 96.39% in 2020, then spiked by 198.52% in 2021.
  • Over the past 4 years, Exelixis' Current Deferred Revenue (Yearly) stood at $182.9 million in 2018, then slumped by 96.39% to $6.6 million in 2020, then declined by 15.93% to $5.5 million in 2021, then soared by 198.52% to $16.6 million in 2021, then fell by 15.00% to $14.1 million in 2022.